(Q37617538)
Statements
1 reference
Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic (English)
1 reference
14 October 2009
1 reference
1 reference
Identifiers
1 reference